Published in Head Neck on July 01, 2007
Emerging drugs to treat squamous cell carcinomas of the head and neck. Expert Opin Emerg Drugs (2010) 1.25
ErbB receptors in the biology and pathology of the aerodigestive tract. Exp Cell Res (2008) 1.17
Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer. Semin Oncol (2008) 1.12
Targeting EGFR resistance networks in head and neck cancer. Cell Signal (2009) 1.07
Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma. J Transl Med (2011) 1.04
Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway. Oncogene (2009) 1.01
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells. Invest New Drugs (2010) 0.87
HER2 as a therapeutic target in head and neck squamous cell carcinoma. Clin Cancer Res (2014) 0.86
Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics. Bioorg Med Chem Lett (2009) 0.85
Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex. Cancer Res (2013) 0.84
Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. Eur Arch Otorhinolaryngol (2010) 0.83
Receptor-tyrosine-kinase-targeted therapies for head and neck cancer. J Signal Transduct (2011) 0.82
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Invest New Drugs (2010) 0.82
Her-2 immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, not Her-2 amplification. Head Neck Pathol (2009) 0.80
Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420. Oncol Rep (2013) 0.79
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors. Virchows Arch (2011) 0.79
Evaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell Carcinoma. Iran J Otorhinolaryngol (2012) 0.78
Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma. Iran J Otorhinolaryngol (2013) 0.77
Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines. Onco Targets Ther (2015) 0.77
ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth. Oncogene (2015) 0.76
Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit. Chin J Cancer (2012) 0.75
Oral mucosal melanoma: a series of case reports. J Craniomaxillofac Surg (2004) 1.47
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas. Am J Clin Pathol (2005) 1.43
Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol (2005) 1.03
Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res (2007) 1.02
Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol (2005) 1.01
Primary duodenal adenocarcinoma. Tumori (2009) 0.96
Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interferon Cytokine Res (2002) 0.93
Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res (2005) 0.93
beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol Rep (2003) 0.91
Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: Preliminary results. Cancer Sci (2010) 0.91
Immunohistochemical expression of basement membrane proteins of verrucous carcinoma of the oral mucosa. Clin Oral Investig (2009) 0.90
Onset of oral extranodal large B-cell non-Hodgkin's lymphoma in a patient with polycythemia vera: a rare presentation. Oral Oncol (2002) 0.89
Angiopoietin 2 induces cell cycle arrest in endothelial cells: a possible mechanism involved in advanced plaque neovascularization. Arterioscler Thromb Vasc Biol (2004) 0.89
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol (2003) 0.88
Vasculogenic potential of long term repopulating cord blood progenitors. FASEB J (2004) 0.86
Overexpression of p27BBP in head and neck carcinomas and their lymph node metastases. Head Neck (2004) 0.86
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx. Cancer (2002) 0.85
Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. Int J Oncol (2009) 0.85
Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (2004) 0.85
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep (2004) 0.84
Biological factors involved in the osseointegration of oral titanium implants with different surfaces: a pilot study in minipigs. J Periodontol (2005) 0.82
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood (2004) 0.82
Playing a brass instrument after total laryngectomy: a case report. Head Neck (2009) 0.82
Towards gene therapy for deafness. J Cell Physiol (2011) 0.82
Histamine inhalation challenge in recurrent uvula angioedema. J Allergy Clin Immunol (2003) 0.80
Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck (2004) 0.79
Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Ann Surg Oncol (2007) 0.79
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study. Am J Clin Oncol (2004) 0.79
IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival. J Immunother (2009) 0.79
Perinatal asphyxia affects rat auditory processing: implications for auditory perceptual impairments in neurodevelopmental disorders. PLoS One (2010) 0.76
Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. Anticancer Res (2003) 0.76
The importance of preoperative swallowing therapy in subtotal laryngectomies. Otolaryngol Head Neck Surg (2009) 0.75
Oral lichenoid lesions: what are they? Oral Oncol (2004) 0.75